Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Recent
Upcoming
Share :

EACR 2012

7 - 10 Jul 2012
Videos

Molecular stratification of breast cancer: reaching the clinic

Prof Carlos Caldas - University of Cambridge, UK
Molecular stratification of breast cancer: reaching the clinic ( Prof Carlos Caldas - University of Cambridge, UK )
25 Jul 2012

Circulating metastasis-initiating cells in breast cancer

Prof Andreas Trumpp - German Cancer Research Centre (DKFZ), Heidelberg, Germany
Circulating metastasis-initiating cells in breast cancer ( Prof Andreas Trumpp - German Cancer Research Centre (DKFZ), Heidelberg, Germany )
19 Jul 2012

The ceRNA Hypothesis and the non-coding revolution in cancer research and therapy

Prof Pier Paolo Pandolfi - Harvard Medical School, Boston, USA
The ceRNA Hypothesis and the non-coding revolution in cancer research and therapy ( Prof Pier Paolo Pandolfi - Harvard Medical School, Boston, USA )
19 Jul 2012

Epithelial mesenchyme transition in cancer cells

Prof Jean-Paul Thiery – Institute of Molecular and Cell Biology, Singapore
Epithelial mesenchyme transition in cancer cells ( Prof Jean-Paul Thiery – Institute of Molecular and Cell Biology, Singapore )
18 Jul 2012

Australia Pancreatic Cancer Genome Initiative

Dr Marina Pajic – The Garvan Institute of Medical Research, Darlinghurst, Australia
Australia Pancreatic Cancer Genome Initiative ( Dr Marina Pajic – The Garvan Institute of Medical Research, Darlinghurst, Australia )
18 Jul 2012

Underlying metabolic pathways in cancer

Dr Arkaitz Carracedo – Ikerbasque, Bilbao, Spain
Underlying metabolic pathways in cancer ( Dr Arkaitz Carracedo – Ikerbasque, Bilbao, Spain )
18 Jul 2012

Potential for micro-RNA based cancer treatments

Prof Carlo Croce – Ohio State University, Columbus, USA
Potential for micro-RNA based cancer treatments ( Prof Carlo Croce – Ohio State University, Columbus, USA )
18 Jul 2012

Understanding the mechanisms of breast cancer resistance

Prof Jos Jonkers – Netherlands Cancer Institute, Amsterdam, Netherlands
Understanding the mechanisms of breast cancer resistance ( Prof Jos Jonkers – Netherlands Cancer Institute, Amsterdam, Netherlands )
18 Jul 2012

Translational and tailored, but can we afford it?

Prof Gordon McVie - European Institute of Oncology and ecancer
Translational and tailored, but can we afford it? ( Prof Gordon McVie - European Institute of Oncology and ecancer )
17 Jul 2012

Translational and tailored, but can we afford it?

Prof Ulrik Ringborg - Karolinska Institute, Stockholm, Sweden
Translational and tailored, but can we afford it? ( Prof Ulrik Ringborg - Karolinska Institute, Stockholm, Sweden )
17 Jul 2012

Cost efficiency of targeted therapy

Dr Maria Grazia Daidone - Foundazione IRCCS Istituto Nazionale dei Tumori, Italy
Cost efficiency of targeted therapy ( Dr Maria Grazia Daidone - Foundazione IRCCS Istituto Nazionale dei Tumori, Italy )
17 Jul 2012

Society and money - the cancer conundrum

Prof Richard Sullivan – Kings College, London, UK
Society and money - the cancer conundrum ( Prof Richard Sullivan – Kings College, London, UK )
17 Jul 2012

Translating cancer research to personalised treatment: Can it work?

Prof Joan Seoane – Vall d’Hebron Institute of Oncology, Spain
Translating cancer research to personalised treatment: Can it work? ( Prof Joan Seoane – Vall d’Hebron Institute of Oncology, Spain )
17 Jul 2012

The immuno side of melanoma

Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA
The immuno side of melanoma ( Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA )
16 Jul 2012

Constructing successful biomarker clinical trials

Dr Lisa McShane – National Cancer Institute, Bethesda, USA
Constructing successful biomarker clinical trials ( Dr Lisa McShane – National Cancer Institute, Bethesda, USA )
16 Jul 2012

Highlights of the 22nd EACR meeting and tackling glioblastoma

Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain
Highlights of the 22nd EACR meeting and tackling glioblastoma ( Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain )
16 Jul 2012

The changing field of drug development

Dr Jonathan Yingling – Oncology Drug Discovery, Eli Lilly
The changing field of drug development ( Dr Jonathan Yingling – Oncology Drug Discovery, Eli Lilly )
16 Jul 2012

Epigenetics of cancer and changes in DNA modification in tumours

Prof Manel Esteller – University of Barcelona, Catalonia, Spain
Epigenetics of cancer and changes in DNA modification in tumours ( Prof Manel Esteller – University of Barcelona, Catalonia, Spain )
16 Jul 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation